bq 610 has been researched along with tezosentan in 1 studies
| Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) |
|---|---|---|---|---|---|
| 124 | 1 | 3 | 157 | 29 | 33 |
| Protein | Taxonomy | bq 610 (IC50) | tezosentan (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.021 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.0205 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, DC; Skovgaard, N; Wang, T; Warren, DE | 1 |
1 other study(ies) available for bq 610 and tezosentan
| Article | Year |
|---|---|
Endothelin-1 causes systemic vasodilatation in anaesthetised turtles (Trachemys scripta) through activation of ETB-receptors.
Topics: Analysis of Variance; Animals; Blood Circulation; Blood Pressure; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Oligopeptides; Peptide Fragments; Piperidines; Pyridines; Receptors, Endothelin; Stroke Volume; Tetrazoles; Turtles; Vasodilation | 2005 |